Phenylalanine Market Size, Trends, Shares, Insights and Forecast – 2018-2026

PHENYLALANINE MARKET ANALYSIS INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2020–2027

REPORT DESCRIPTION Phenylalanine - Overview Moreover, high prevalence of chronic pain diseases is expected to foster the growth of Phenylalanine Market over the forecast period. For instance, according to the American Academy of Pain Medicine (AAPM), in 2011, around 1.8 billion people suffered from chronic pain. Moreover, the National Institutes of Health (NIH) estimates that one in 10 people in the U.S. suffer from chronic pain. According to a study published in the British Medical Journal in 2016, nearly one-third to half of the population in the U.K. suffers from chronic pain. Moreover, according to the NIH estimates published in 2015 by the American Pain Society, around 50 million people in the U.S. suffered from chronic pain. Phenylalanine is essential alpha amino acid, which functions to maintain adequate levels of monoamine neurotransmitters in the brain, thereby maintaining balanced moods. Deficiency of phenylalanine causes mental confusion, depression, reduced alertness, memory impairment, and loss of appetite. Phenylalanine is majorly present in three forms: DPhenylalanine, DL-Phenylalanine, and L-Phenylalanine. L-phenylalanine is natural amino acid found in the proteins, while D-Phenylalanine is synthesized form of phenylalanine, produced in laboratory. DL-phenylalanine is synthetic product made of 50% D-phenylalanine and 50% of L-phenylalanine. L-phenylalanine is an essential amino acid, which is also an only form of phenylalanine found in proteins. Browse Research Reports: https://www.coherentmarketinsights.com/ongoinginsight/phenylalanine-market-1828 © Coherent market Insights. All Rights Reserved

REPORT DESCRIPTION Phenylalanine Market Drivers Increasing prevalence of anxiety and depression are responsible for massive consumptions of anti-depressants, in turn promoting global phenylalanine market growth. For instance, according to the World Health Organization (WHO) data findings, in 2017, over 300 million people of all ages are suffering from depression worldwide, wherein around 800,000 people die due to suicide due to anxiety disorders and depression as prime cause. Moreover, according to the National Institute of Mental Health (NIMH), in 2016, an estimated 10.3 million U.S. adults (4.3% of all U.S. adults) aged 18 or older had at least one major depressive episode with severe impairment. Furthermore, according to the same source, the prevalence of major depressive cases was higher among adult females (8.5%) as compared to males (4.8%). Furthermore, the prevalence of adults with a major depressive episode was highest among individuals aged 18-25 (10.9%). The association (NIMH) also mentions that these disorders are highly treatable thereby propelling opportunities for growth of the global phenylalanine market. Furthermore, increasing prevalence of pain and chronic diseases such as cancer and others are driving growth of the phenylalanine market. For instance, according to the National Cancer Institute, in 2018, around 1,735,350 new cases of cancer are expected to be diagnosed in the U.S. and 609,640 people are expected to die from the disease. Request a Sample copy of this reports: https://www.coherentmarketinsights.com/insight/request-sample/1828 © Coherent market Insights. All Rights Reserved

REPORT DESCRIPTION Phenylalanine Market – Regional Analysis Geographically, the global phenylalanine market is segmented into North America, Latin America, Europe, Middle East, Asia Pacific, and Africa. Increasing incidence of cancer and rising number of trauma cases worldwide is propelling demand for pain management associated with it. North America phenylalanine market is expected to witness significant growth during the forecast period. As per statistics published by Centers for Disease Control and Prevention (CDC), in 2014, trauma accounts for 41 million visits to the emergency ward each year in the U.S. Furthermore, developed economies such as the U.S., U.K. and Germany experience high rate of adoption due to better healthcare facilities and easy availability of depression medication in these countries. According to the American academy of pain medicine, every year, over 100 million people suffer from chronic pain, 25.8 million from diabetes, 16.3 million from coronary heart disease, and 11.9 million from cancer in the U.S. This number is expected to further increase in the near future.

Increasing research and development initiatives by various government and non-governmental organizations such as National Institutes of Health (NIH) Brain Research through Advancing Innovative Neurotechnologies (BRAIN), which aims to better understand the human brain and harness the same for various therapeutic applications, including effective pain management, is expected to create a conducive environment for market growth in these region.

ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele.

SERVICES INDUSTRY ANALYSIS

CUSTOMIZED RESEARCH

SYNDICATED RESEARCH

MARKET INTELLIGENCE SERVICES

CONSULT STUDIES

COUNTRY SPECIFIC STUDIES

ABOUT CMI SECTOR COVERAGE

BIOTECHNOLOGY

CLINICAL DIAGNOSTIC

HEALTHCARE IT

MEDICAL DEVICES

MEDICAL IMAGING

PHARMACEUTICAL

OUR CLIENTS

 Global Leading Equipment and System Manufacturers  Marketing Consultancies and the Advertising Industry  Component Providers and System Integrators

 Private and Government organization

 Distributors, Retailors and Value Added Resellers

 Outsourcing Companies

 Healthcare IT Solutions Developers

 Universities and Business Schools.

KEY STATS

RESEARCH SOLUTIONS

100+

FEASIBILITY STUDIES

Insights Published Per Year

GLOBAL REPORTS

150+

Consulting Projects Till Date

COUNTRY ANALYSIS CONSULT PROJECTS

125+

Clients Worldwide Per Year

110+

SURVEY RESEARCH

EXCEL FORECAST DATABASE

CUSTOMIZED SOLUTIONS

COMPETITIVE ASSESSMENT TECHNOLOGY SNIPPETS

Analysts and Contract Consultants

Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. © Coherent market Insights. All Rights Reserved

THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702

Turn static files into dynamic content formats.

Create a flipbook